These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 29329521

  • 1. Treating C3 glomerulopathy with eculizumab.
    Welte T, Arnold F, Kappes J, Seidl M, Häffner K, Bergmann C, Walz G, Neumann-Haefelin E.
    BMC Nephrol; 2018 Jan 12; 19(1):7. PubMed ID: 29329521
    [Abstract] [Full Text] [Related]

  • 2. Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.
    Le Quintrec M, Lapeyraque AL, Lionet A, Sellier-Leclerc AL, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Frémeaux-Bacchi V, Fakhouri F.
    Am J Kidney Dis; 2018 Jul 12; 72(1):84-92. PubMed ID: 29429752
    [Abstract] [Full Text] [Related]

  • 3. Eculizumab for dense deposit disease and C3 glomerulonephritis.
    Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB.
    Clin J Am Soc Nephrol; 2012 May 12; 7(5):748-56. PubMed ID: 22403278
    [Abstract] [Full Text] [Related]

  • 4. Successful Treatment of Posttransplant Recurrent Complement C3 Glomerulopathy with Eculizumab.
    Sahin H, Gok Oguz E, Akoglu H, Atilgan G, Ulusal Okyay G, Karaveli Gursoy G, Kip Teymur T, Ertoy D, Canbakan B, Ayli MD.
    Iran J Kidney Dis; 2018 Oct 12; 12(5):315-318. PubMed ID: 30367025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study.
    Welte T, Arnold F, Westermann L, Rottmann FA, Hug MJ, Neumann-Haefelin E, Ganner A.
    BMC Nephrol; 2023 Jan 11; 24(1):8. PubMed ID: 36631797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of C3 glomerulopathy with complement blockers.
    Vivarelli M, Emma F.
    Semin Thromb Hemost; 2014 Jun 11; 40(4):472-7. PubMed ID: 24799307
    [Abstract] [Full Text] [Related]

  • 9. C3 glomerulopathy and eculizumab: a report on four paediatric cases.
    Lebreton C, Bacchetta J, Dijoud F, Bessenay L, Fremeaux-Bacchi V, Sellier-Leclerc AL.
    Pediatr Nephrol; 2017 Jun 11; 32(6):1023-1028. PubMed ID: 28236143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathology after eculizumab in dense deposit disease and C3 GN.
    Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.
    J Am Soc Nephrol; 2012 Jul 11; 23(7):1229-37. PubMed ID: 22677550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eculizumab in post-transplant C3 glomerulonephritis caused by a C3 mutation
.
    Kim JS, Foster KW, Westphal SG.
    Clin Nephrol; 2020 Jan 11; 93(1):51-56. PubMed ID: 31661064
    [Abstract] [Full Text] [Related]

  • 14. A case of C3 glomerulonephritis successfully treated with eculizumab.
    Payette A, Patey N, Dragon-Durey MA, Frémeaux-Bacchi V, Le Deist F, Lapeyraque AL.
    Pediatr Nephrol; 2015 Jun 11; 30(6):1033-7. PubMed ID: 25796589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J.
    Pediatr Nephrol; 2018 Dec 11; 33(12):2289-2298. PubMed ID: 30238151
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.
    Al-Ghaithi B, Chanchlani R, Riedl M, Thorner P, Licht C.
    Pediatr Nephrol; 2016 Nov 11; 31(11):2079-86. PubMed ID: 27008643
    [Abstract] [Full Text] [Related]

  • 20. C3 glomerulopathy: A new complement-based entity.
    de Lorenzo A, Tallón S, Hernández-Sevillano B, de Arriba G.
    Rev Clin Esp (Barc); 2014 Nov 11; 214(5):266-74. PubMed ID: 24576419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.